Epithelial mesenchymal transition from a natural gestational orchestration to a bizarre cancer disturbance

Cancer Science

Volumn 104, Issue 1, 2013, Pages 28-35

  Shirkoohi, Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER THERAPY; CARCINOGENESIS; CELL FUNCTION; CELL JUNCTION; CELL STRUCTURE; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSIS; HEALING; HUMAN; MALIGNANT TRANSFORMATION; MESENCHYME CELL; METASTASIS; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; REVIEW; STEM CELL; TUMOR MICROENVIRONMENT;

ANIMALS; EMBRYONIC DEVELOPMENT; EMBRYONIC STEM CELLS; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; GASTRULATION; HUMANS; MESENCHYMAL STROMAL CELLS; NEOPLASM METASTASIS; NEOPLASMS; WOUND HEALING;

EID: 84872267912     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12074     Document Type: Review

References (93)

1. Radisky D. Epithelial-mesenchymal transition. J Cell Sci 2005; 118: 4325.
2. Thiery J. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15: 740-6.
3. Kong D, Li Y, Wang Z, Sarkar F. Cancer stem cells and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: are they cousins or twins? Cancers 2011; 3: 716-29.
4. Lee J, Dedhar S, Kalluri R, Thompson E. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006; 172: 973-81.
5. Iwatsuki M, Mimori K, Yokobori T et al. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 2010; 101: 293-9.
6. Moustakas A, Heldin C. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 2007; 98: 1512-20.
7. McCaffrey L, Macara IG. Epithelial organization, cell polarity and tumorigenesis. Trends Cell Biol 2011; 21: 727-35.
8. Royer C, Lu X. Epithelial cell polarity: a major gatekeeper against cancer? Cell Death Differ 2011; 18: 1470-7.
9. Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J. Molecular Cell Biology. 6th edn. New York: W H Freeman, 2007.
10. Ozawa M, Baribault H, Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 1989; 8: 1711-7.
11. Peyriéras N, Louvard D, Jacob F. Characterization of antigens recognized by monoclonal and polyclonal antibodies directed against uvomorulin. Proc Natl Acad Sci USA 1985; 82: 8067-71.
12. Reynolds A. Epithelial organization: new perspective on α-catenin from an ancient source. Curr Biol 2011; 21: R430-2.
13. Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci 2003; 94: 575-81.
14. Rangarajan E, Izard T. α-Catenin unfurls upon binding to vinculin. J Biol Chem 2012; 287: 18492-9.
15. Mosimann C, Hausmann G, Basler K. Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nat Rev Mol Cell Biol 2009; 10: 276-86.
16. MacDonald B, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009; 17: 9-26.
17. Tripathi V, Popescu N, Zimonjic D. DLC1 interaction with α-catenin stabilizes adherens junctions and enhances DLC1 antioncogenic activity. Mol Cell Biol 2012; 32: 2145-59.
18. Guardavaccaro D, Clevers H. Wnt/β-Catenin and MAPK Signaling: allies and Enemies in Different Battlefields. Sci Signal 2012; 5: pe15.
19. Flores E, Halder G. Stem cell proliferation in the skin: alpha-catenin takes over the hippo pathway. Sci Signal 2011; 4: pe34.
20. Perez-Moreno M, Davis M, Wong E, Pasolli H, Reynolds A, Fuchs E. p120-catenin mediates inflammatory responses in the skin. Cell Biosci 2006; 124: 631-44.
21. Garcia-Gras E, Lombardi R, Giocondo M et al. Suppression of canonical Wnt/β-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest 2006; 116: 2012-21.
22. Gumbiner B. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996; 84: 345-57.
23. Hulpiau P, Van Roy F. Molecular evolution of the cadherin superfamily. Int J Biochem Cell Biol 2009; 41: 349-59.
24. Bello S, Millo H, Rajebhosale M, Price S. Catenin-dependent cadherin fuction drives divisional segregation of spinal chord motor neurons. J Neuroscience 2012; 32: 490-505.
25. Offermanns S, Rosenthal W. Encyclopedia of Molecular Pharmacology. Verlag Berlin: Springer, 2008.
26. Huntsman D, Caldas C. Assignment1 of the E-cadherin gene (CDH1) to chromosome 16q22.1 by radiation hybrid mapping. Cytogenet Cell Genet 1999; 83: 82-3.
27. Wong A, Gumbiner B. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J Cell Biol 2003; 161: 1191-203.
28. Weinberg R. The Biology of Cancer. New York: Taylor & Francis, 2006.
29. Rosen P. Rosen's Breast Pathology. 3rd edn. Philadelphia: Lippincott Williams & Wilkins, 2009.
30. Reid R, Hemperly J. Human N-cadherin: nucleotide and deduced amino acid sequence. Nucleic Acids Res 1990; 18: 5896.
31. Ramis-Conde I, Chaplain M, Anderson A, Drasdo D. Multi-scale modelling of cancer cell intravasation: the role of cadherins in metastasis. Phys Biol 2009; 6: 016008.
32. Selig S, Bruno S, Scharf J et al. Expressed cadherin pseudogenes are localized to the critical region of the spinal muscular atrophy gene. Proc Natl Acad Sci USA 1995; 92: 3702-6.
33. Kaupmann K, Becker-Follmann J, Scherer G, Jockusch H, Starzinski-Powitz A. The gene for the cell adhesion molecule M-cadherin maps to mouse chromosome 8 and human chromosome 16q24.1-qter and is near the E-cadherin (uvomorulin) locus in both species. Genomics 1992; 14: 488-90.
34. Rüffer C, Gerke V. The C-terminal cytoplasmic tail of claudins 1 and 5 but not its PDZ-binding motif is required for apical localization at epithelial and endothelial tight junctions. Eur J Cell Biol 2004; 83: 135-44.
35. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998; 7: 1539-50.
36. Ando-Akatsuka Y, Saitou M, Hirase T et al. Interspecies diversity of the occludin sequence: cDNA cloning of human, mouse, dog, and rat-kangaroo homologues. J Cell Biol 1996; 133: 43-7.
37. Furuse M, Hirase T, Itoh M et al. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993; 123: 1777-88.
38. Ikenouchi J, Matsuda M, Furuse M, Tsukita S. Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci 2003; 116: 1959-67.
39. Willecke K, Eiberger J, Degen J et al. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 2002; 383: 725-37.
40. Rutkowski R, Kosztyła-Hojna B, Kańczuga-Koda L, Sulkowska M, Sulkowski S, Rutkowski K. Structure and physiological function of connexin proteins. Postepy Hig Med Dosw (Online) 2008; 62: 632-41.
41. Govindarajan R, Chakraborty S, Johnson K et al. Assembly of connexin43 into gap junctions is regulated differentially by E-cadherin and N-cadherin in rat liver epithelial cells. Mol Biol Cell 2010; 21: 4089-107.
42. Strum J, Gartner L, Hiatt J. Cell biology and histology. MD H, edn. Philadelphia: Lippincott Williams & Wilkins, 2007.
43. Hellingman C, Davidson E, Koevoet W et al. Smad signaling determines chondrogenic differentiation of bone-marrow-derived mesenchymal stem cells: inhibition of Smad1/5/8P prevents terminal differentiation and calcification. Tissue Eng Part A 2011; 17: 1157-67.
44. Park S, Seo K, So A et al. SOX2 has a crucial role in the lineage determination and proliferation of mesenchymal stem cells through Dickkopf-1 and c-MYC. Cell Death Differ 2012; 19: 534-45.
45. Lo H, Xia W, Wei Y, Ali-Seyed M, Huang S, Hung M. Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res 2005; 65: 338-48.
46. Zavadil J, Bottinger E. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005; 24: 5764-74.
47. Wu Y, Zhou B. New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin (Shanghai) 2008; 40: 643-50.
48. Gross J, Lapiere C. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA 1962; 15: 1014-22.
49. Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 2010; 1803: 55-71.
50. Van Lint P, Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 2007; 82: 1375-81.
51. Kajita M, Itoh Y, Chiba T et al. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 2001; 153: 893-902.
52. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-74.
53. Lafleur M, Handsley M, Edwards D. Metalloproteinases and their inhibitors in angiogenesis. Expert Rev Mol Med 2003; 5: 1-39.
54. Darmanin S, Chen J, Zhao S et al. All-trans retinoic acid enhances murine dendritic cell migration to draining lymph nodes via the balance of matrix metalloproteinases and their inhibitors. J Immunol 2007; 179: 4616-25.
55. Woodhouse E, Chuaqui R, Liotta L. General mechanisms of metastasis. Cancer Cell 1997; 80: 1529-37.
56. Zucker S, Pei D, Cao J, Lopez-Otin C. Membrane type-matrix metalloproteinases (MT-MMP). Curr Top Dev Biol 2003; 54: 1-72.
57. Sternlicht M, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17: 463-516.
58. Vicovac L, Aplin J. Epithelial-mesenchymal transition during trophoblast differentiation. Acta Anat (Basel) 1996; 156: 202-16.
59. Bischof P, Aplin J, Bentin-Ley U et al. Implantation of the human embryo: research lines and models From the implantation research network 'Fruitful'. Gynecol Obstet Invest 2006; 62: 206-16.
60. Hay E. Role of cell-matrix contacts in cell migration and epithelial-mesenchymal transformation. Cell Differ Dev 1990; 32: 367-75.
61. Thiery J, Sleeman J. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-42.
62. Hay E. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 1995; 154: 8-20.
63. Skromne I, Stern C. Interactions between Wnt and Vg1 signalling pathways initiate primitive streak formation in the chick embryo. Development 2001; 128: 2915-27.
64. Popperl H, Schmidt C, Wilson V et al. Misexpression of Cwnt8C in the mouse induces an ectopic embryonic axis and causes a truncation of the anterior neuroectoderm. Development 1997; 124: 2997-3005.
65. Chea H, Wright C, Swalla B. Nodal signaling and the evolution of deuterostome gastrulation. Dev Dyn 2005; 234: 269-78.
66. Zhao H, Yang Y, Partanen J, Ciruna B, Rossant J, Robinson M. Fibroblast growth factor receptor 1 (Fgfr1) is not essential for lens fiber differentiation in mice. Mol Vis 2006; 12: 15-25.
67. Arnold S, Hofmann U, Bikoff E, Robertson E. Pivotal roles for eomesodermin during axis formation, epithelium-to-mesenchyme transition and endoderm specification in the mouse. Development 2008; 135: 501-11.
68. Whiteman E, Liu C, Fearon E, Margolis B. The transcription factor snail represses Crumbs3 expression and disrupts apico-basal polarity complexes. Oncogene 2008; 27: 3875-9.
69. Duband J, Thiery J. Appearance and distribution of fibronectin during chick embryo gastrulation and neurulation. Dev Biol 1982; 94: 337-50.
70. Karafiat V, Dvorakova M, Pajer P, Cermak V, Dvorak M. Melanocyte fate in neural crest is triggered by Myb proteins through activation of c-kit. Cell Mol Life Sci 2007; 64: 2975-84.
71. Potenta S, Zeisberg E, Kalluri R. The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer 2008; 99: 1375-9.
72. Okada H, Danoff T, Kalluri R, Neilson E. Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 1997; 273: F563-74.
73. Zeisberg M, Hanai J, Sugimoto H et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9: 964-8.
74. Zeisberg E, Tarnavski O, Zeisberg M et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13: 952-61.
75. Hanahan D, Weinberg R. The hallmarks of cancer. Cell 2000; 100: 57-70.
76. Yang J, Weinberg R. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008; 14: 818-29.
77. Thiery J. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442.
78. Smit M, Peeper D. Deregulating EMT and senescence: double impact by a single twist. Cancer Cell 2008; 14: 5-7.
79. Medici D, Hay E, Olsen B. Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol Biol Cell 2008; 19: 4875-87.
80. Tse J, Kalluri R. Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 2007; 101: 816-29.
81. Bierie B, Moses H. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 2006; 6: 506-20.
82. Tepass U, Truong K, Godt D, Ikura M, Peifer M. Cadherins in embryonic and neural morphogenesis. Nat Rev Mol Cell Biol 2000; 1: 91-100.
83. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998; 153: 333-9.
84. Shirkoohi R. Ability of actin-regulatory protein, gelsolin in induction of monocytic leukemia cell differentiation. Hokkaido Igaku Zasshi 2006; 81: 159-67.
85. Tanaka H, Shirkoohi R, Nakagawa K et al. siRNA gelsolin knockdown induces epithelial-mesenchymal transition with a cadherin switch in human mammary epithelial cells. Int J Cancer 2006; 118: 1680-91.
86. Stockinger A, Eger A, Wolf J, Beug H, Foisner R. E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. J Cell Biol 2001; 154: 1185-96.
87. Savad S, Mehdipour P, Miryounesi M et al. Expression analysis of MiR-21, MiR-205, and MiR-342 in Breast Cancer in Iran. Asian Pac J Cancer Prev 2012; 13: 873-7.
88. Gregory P, Bert A, Paterson E et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601.
89. Zavadil J, Narasimhan M, Blumenberg M, Schneider R. Transforming growth factor-beta and microRNA: mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs 2007; 185: 157-61.
90. Zeisberg M, Shah A, Kalluri R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem 2005; 280: 8094-100.
91. Brabletz T, Jung A, Reu S et al. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 2001: 98: 10356-61.
92. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010; 29: 4741-51.
93. Vazquez-Martin A, Oliveras-Ferraros C, Cufí S, Del Barco S, Martin-Castillo B, Menendez J. Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status. Cell Cycle 2010; 9: 3807-14.